Literature DB >> 6306192

Comparison of ceftriaxone with standard therapy for bacterial meningitis.

R W Steele, R W Bradsher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306192     DOI: 10.1016/s0022-3476(83)80801-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  23 in total

1.  Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

Authors:  D Kalman; S L Barriere
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.

Authors:  K Prasad; A Kumar; P K Gupta; T Singhal
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

3.  Bacterial meningitis in India: an IJP survey.

Authors:  S K Kabra; P Kumar; I C Verma; D Mukherjee; B H Chowdhary; S Sengupta; R N Singh; S P Khatua; N Miglani; K M Sehai
Journal:  Indian J Pediatr       Date:  1991 Jul-Aug       Impact factor: 1.967

4.  Ceftriaxone in the treatment of meningitis, gonococcal infections and other serious bacterial infections. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1990-03-01       Impact factor: 8.262

5.  In vitro antibiotic sensitivity pattern of common bacterial isolates from cases of acute bacterial meningitis with special reference to ceftriaxone.

Authors:  B N Rao; I M Kashbur; N M Shembesh; S M el Bargathy
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

6.  Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae.

Authors:  J H Jorgensen; L A Maher; J S Redding
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

7.  Current antibiotic usage, I: Penicillins, cephalosporins and chloramphenicol.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

Review 8.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

9.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis.

Authors:  B L Congeni
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 10.  Adverse effects of newer cephalosporins. An update.

Authors:  J W Thompson; R F Jacobs
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.